Pharmaceutical Product Development (PPD) and Shin Nippon Biomedical Laboratories (SNBL) have formed a joint venture to provide clinical development services in Japan. With the completion of the deal, PPD-SNBL is one of the largest clinical development service providers in Japan, both for clients seeking to conduct global clinical trials and for trials based solely in Japan. The new company combines SNBL’s clinical research division and PPD’s clinical development operations in Japan and pro...